(0.10%) 5 251.75 points
(0.03%) 39 653 points
(0.21%) 18 294 points
(0.01%) $78.27
(1.15%) $2.28
(-0.83%) $2 355.30
(-0.53%) $28.36
(0.20%) $1 009.20
(-0.01%) $0.928
(0.29%) $10.86
(0.03%) $0.799
(-0.91%) $91.83
Quarter results today
(bmo 2024-05-13)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States...
Stats | |
---|---|
Today's Volume | 101 134 |
Average Volume | 223 483 |
Market Cap | 20.36M |
EPS | $0 ( 2024-04-02 ) |
Next earnings date | ( $-0.120 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.670 |
ATR14 | $0.00400 (1.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-06 | Equels Thomas K | Buy | 61 729 | Common Stock |
2024-05-06 | Rodino Peter W Iii | Buy | 30 865 | Common Stock |
2023-11-30 | Rodino Peter W Iii | Buy | 100 000 | Options |
2023-11-30 | Equels Thomas K | Buy | 300 000 | Options |
2024-03-21 | Bryan Nancy | Buy | 38 462 | Common Stock |
INSIDER POWER |
---|
90.42 |
Last 98 transactions |
Buy: 4 074 490 | Sell: 118 208 |
Volume Correlation
AIM ImmunoTech Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AIM ImmunoTech Inc Correlation - Currency/Commodity
AIM ImmunoTech Inc Financials
Annual | 2023 |
Revenue: | $202 000 |
Gross Profit: | $-78 000.00 (-38.61 %) |
EPS: | $-0.600 |
FY | 2023 |
Revenue: | $202 000 |
Gross Profit: | $-78 000.00 (-38.61 %) |
EPS: | $-0.600 |
FY | 2022 |
Revenue: | $141 000 |
Gross Profit: | $-19.78M (-14 029.79 %) |
EPS: | $-0.440 |
FY | 2021 |
Revenue: | $135 000 |
Gross Profit: | $-715 000 (-529.63 %) |
EPS: | $-0.400 |
Financial Reports:
No articles found.
AIM ImmunoTech Inc
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat genital warts, a sexually transmitted disease. It has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators